ASAIO Journal

Journal

Publication Venue For

  • Evaluation of Bivalirudin Dosing in Pediatric Extracorporeal Membrane Oxygenation with Renal Insufficiency or Renal Replacement Therapy..  68:e196-e203. 2022
  • Pulmonary Transplant After More Than 1 Year of Continuous Ambulatory Extracorporeal Support.  68:E172. 2022
  • BIO5: Development an in Vitro System To Investigate The Impact Of Pulsatility On Endothelial Von Willebrand.  68:10-11. 2022
  • Identification of Biomarkers Sensitive to Pulsatile and Continuous Flow for Identification of Promising Continuous Flow VAD Modulation Protocols to Mitigate Non-Surgical Bleeding Events.  68:1-1. 2022
  • Outcomes of Durable Mechanical Circulatory Support in Myocarditis: Analysis of the International Society for Heart and Lung Transplantation Registry for Mechanically Assisted Circulatory Support Registry.  68:190-196. 2022
  • Biventricular Support Using ProtekDuo Cannula in a Child.  67:E124-E126. 2021
  • Gender Differences in Mortality After Left Ventricular Assist Device Implant: A Causal Mediation Analysis Approach.  67:614-621. 2021
  • Improvement in kidney function after ventricular assist device implantation and its influence on thromboembolism, hemorrhage, and mortality.  268-276. 2020
  • Innovation in Medical Devices-Lessons from the Past, Planning for the Future: Hastings Lecture 2019.  65:E82-E85. 2019
  • Left ventricular assist device thrombosis- A miodarone-induced hyperthyroidism: Causal link?.  65:E18-E20. 2019
  • Performance of noninvasive assessment in the diagnosis of right heart failure after left ventricular assist device.  65:449-455. 2019
  • Use of computed tomography in preoperative planning for heartware left ventricular assist device placement.  65:70-76. 2019
  • Association of pulsatility with gastrointestinal bleeding in a cohort of HeartMate II recipients.  64:472-479. 2018
  • Use of durable continuous-flow ventricular assist devices in patients on immunosuppression.  64:334-337. 2018
  • Anticoagulation control in patients with ventricular assist devices.  63:759-765. 2017
  • Automated rotational percussion bed and bronchoscopy improves respiratory mechanics and oxygenation in ARDS patients supported with extracorporeal membrane oxygenation.  62:e27-e29. 2016
  • Early implementation of video capsule enteroscopy in patients with left ventricular assist devices and obscure gastrointestinal bleeding.  62:40-45. 2016
  • Heart transplant survival based on recipient and donor risk scoring: A UNOS database analysis.  62:297-301. 2016
  • Predictors of thromboembolic events in patients with ventricular assist device.  61:640-647. 2015
  • A nitric oxide-releasing self-assembled peptide amphiphile nanomatrix for improving the biocompatibility of microporous hollow fibers.  61:589-595. 2015
  • Use of ECMO in the management of severe acute respiratory distress syndrome: A survey of academic medical centers in the United States.  61:556-563. 2015
  • Transhepatic Cannulation for Venovenous Extracorporeal Membrane Oxygenation.  61:e29-e30. 2015
  • Anti-Xa directed protocol for anticoagulation management in children supported with extracorporeal membrane oxygenation.  61:339-344. 2015
  • Modern use of extracorporeal life support in pregnancy and postpartum.  61:110-114. 2015
  • Octreotide in the management of recurrent gastrointestinal bleed in patients supported by continuous flow left ventricular assist devices.  61:107-109. 2015
  • Antithrombin III supplementation on extracorporeal membrane oxygenation: Impact on heparin dose and circuit life.  60:57-62. 2014
  • Cancer in end-stage heart failure patients supported by left ventricular assist devices.  60:609-612. 2014
  • Gastrointestinal bleeding in patients with ventricular assist devices is highest immediately after implantation.  59:480-485. 2013
  • Use of retrospectively gated CT angiography to diagnose systolic LVAD inflow obstruction.  59:542-546. 2013
  • The evolution of extracorporeal life support as a bridge to lung transplantation.  59:3-10. 2013
  • Abdominal compartment syndrome in newborns and children supported on extracorporeal membrane oxygenation.  58:143-147. 2012
  • Comparison of observed survival after ventricular assist device placement versus predicted survival without assist device using the seattle heart failure model.  58:93-97. 2012
  • Hemolysis during cardiac extracorporeal membrane oxygenation: A case-control comparison of roller pumps and centrifugal pumps in a pediatric population.  57:456-461. 2011
  • Accidental azygos vein extracorporeal membrane oxygenation cannulation in a neonate with premature closure of the ductus arteriosus.  57:344-345. 2011
  • Use of gated cardiac computed tomography angiography in the assessment of left ventricular assist device dysfunction.  57:32-37. 2011
  • Hemodynamic responses to continuous versus pulsatile mechanical unloading of the failing left ventricle.  56:410-416. 2010
  • Clot lifespan model analysis of the effects of warfarin on thrombus growth and fibrinolysis: Role of contact protein and tissue factor initiation.  55:33-40. 2009
  • Acute hemodynamic efficacy of a 32-ml subcutaneous counterpulsation device in a calf model of diminished cardiac function.  54:578-584. 2008
  • Mechanical circulatory device thrombosis: A new paradigm linking hypercoagulation and hypofibrinolysis.  54:351-358. 2008
  • Managing device infections: Are we progressing or is infection an insurmountable obstacle?.  51:452-455. 2005
  • How to run an outpatient VAD program: Overview.  47:588-589. 2001
  • Infection with clinical ventricular assist devices: Clinical therapy.  47:195-196. 2001
  • Cost-benefit analysis of extended antifungal prophylaxis in ventricular assist devices.  46:587-589. 2000
  • Fungal infections in ventricular assist devices.  46. 2000
  • High flux plasma exchange using a modified rotating membrane system.  42:957-960. 1996
  • Measurement of percent oxyhemoglobin by optical densitometry in perfluorocarbon supplemented blood.  42. 1996
  • Left atrial or ventricular cannulation beyond 30 days for a Thoratec ventricular assist device.  41. 1995
  • Perfluorocarbons are effective oxygen carriers in cardiopulmonary bypass.  41. 1995
  • Influence of longer term left ventricular assist device support on valvular regurgitation.  40. 1994
  • Perfluorocarbon oxygen transport: A comparative study of four oxygenator designs.  40. 1994
  • International Standard Serial Number (issn)

  • 1058-2916
  • Electronic International Standard Serial Number (eissn)

  • 1538-943X